Literature DB >> 32582514

Primary anorectal malignant melanoma with laparoscopic abdominoperineal resection: a case study and review of the relevant literature.

Kentaro Nonaka1, Kensuke Kudou1,2, Shun Sasaki1, Tomoko Jogo1, Kosuke Hirose1, Yuta Kasagi1, Qingjiang Hu1, Yasuo Tsuda1, Yuichi Hisamatsu1, Koji Ando1, Yuichiro Nakashima1, Hiroshi Saeki1, Eiji Oki1, Mitsuo Kamori1,3, Masaki Mori1.   

Abstract

ARMM is a disease with a poor prognosis. ARMM is often diagnosed at an advanced stage, and the 5-year survival rate of ARMM is < 20%. Although the number of case reports on ARMM is gradually increasing, the optimal treatment strategy for ARMM remains controversial. We report the case of an 81-year-old woman who had experienced bloody stool for 6 months before her diagnosis and who had been initially diagnosed with hemorrhoids. The pathological diagnosis of a biopsy specimen was malignant melanoma. Other examinations showed no evidence of lymph node or distant metastasis. Based on these results, laparoscopic abdominoperineal resection was performed. Three months later on her first follow-up examination, distant metastasis to the lung and liver was detected. Immunotherapy using Nivolumab was initiated to treat the recurrent disease. We reviewed the characteristics of a total of 1834 ARMM patients described in previous reports on ARMM for which the full text was available on PubMed. We experienced a case of ARMM. The prognosis of ARMM is still poor, regardless of the surgical procedure. Previous studies and our case report suggest that systemic therapy, such as immunotherapy using an anti-PD-1 ligand may be more important than reinforcement of local control for improving the prognosis of ARMM patients. © The Japan Society of Clinical Oncology 2020.

Entities:  

Keywords:  Anorectal malignant melanoma; Laparoscopic abdominoperineal resection; PD-1

Year:  2020        PMID: 32582514      PMCID: PMC7297936          DOI: 10.1007/s13691-020-00401-x

Source DB:  PubMed          Journal:  Int Cancer Conf J        ISSN: 2192-3183


  46 in total

1.  A pilot study of extralevator abdominoperineal excision for primary melanoma of the anorectum.

Authors:  H J M Ferguson; S Nandi; R K Hejmadi; T Ismail
Journal:  Tech Coloproctol       Date:  2014-08-26       Impact factor: 3.781

2.  [Primary anorectal melanoma. Apropos of 19 cases].

Authors:  P Dubé; D Elias; S Bonvalot; A Spatz; P Lasser
Journal:  J Chir (Paris)       Date:  1997-05

3.  Changing epidemiology of anorectal melanoma.

Authors:  B Cagir; M H Whiteford; A Topham; J Rakinic; R D Fry
Journal:  Dis Colon Rectum       Date:  1999-09       Impact factor: 4.585

4.  Surgical treatment of anorectal melanomas.

Authors:  B Siegal; D Cohen; E T Jacob
Journal:  Am J Surg       Date:  1983-09       Impact factor: 2.565

5.  Primary melanomas of the esophagus and anorectum: epidemiologic comparison with melanoma of the skin.

Authors:  Timothy R Coté; Leslie H Sobin
Journal:  Melanoma Res       Date:  2009-02       Impact factor: 3.599

6.  Surgical treatment for anorectal malignant melanoma: report of five cases and review of 79 Japanese cases.

Authors:  Satoshi Ishizone; Naohiko Koide; Fumitoshi Karasawa; Noriyuki Akita; Futoshi Muranaka; Hisashi Uhara; Shinichi Miyagawa
Journal:  Int J Colorectal Dis       Date:  2008-07-17       Impact factor: 2.571

7.  Patterns of failure in anorectal melanoma. A guide to surgical therapy.

Authors:  M Ross; C Pezzi; T Pezzi; D Meurer; R Hickey; C Balch
Journal:  Arch Surg       Date:  1990-03

8.  Laparoscopic abdomino-perineal resection for patients with anorectal malignant melanoma: a report of 4 cases.

Authors:  Jun Han; Chuanbing Shi; Xiaogang Dong; Jie Wang; Hao Wen; Baolin Wang; Zhenyu He
Journal:  J Biomed Res       Date:  2013-06-01

9.  Primary rectal melanoma.

Authors:  A Reid; A Dettrick; C Oakenful; Al Lambrianides
Journal:  J Surg Case Rep       Date:  2011-11-01

10.  Anorectal malignant melanoma: curative abdominoperineal resection: patient selection with 18F-FDG-PET/CT.

Authors:  Claudius Falch; Sven Mueller; Andreas Kirschniak; Manuel Braun; Alfred Koenigsrainer; Bernhard Klumpp
Journal:  World J Surg Oncol       Date:  2016-07-15       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.